Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04409457
Other study ID # GCO 19-1047
Secondary ID K23MH118418
Status Recruiting
Phase N/A
First received
Last updated
Start date September 18, 2020
Est. completion date July 31, 2024

Study information

Verified date October 2023
Source Icahn School of Medicine at Mount Sinai
Contact Maia Chester, BA
Phone 212-659-8799
Email maia.chester@mssm.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study examines the influence of acute fasting and eating on self-control in adult females with and without bulimia nervosa (BN). Specifically, the study team is investigating whether differences in behavior and brain activation in response to computer tasks after fasting and after eating a meal could help to explain the symptoms of bulimia nervosa. Data will be collected using questionnaires and a technology called magnetic resonance imaging (MRI).


Description:

Treatment-resistant binge eating and purging may be perpetuated by self-control deficits linked to reduced activation in frontostriatal circuits. To date, however, neurocognitive studies of BN have not assessed the dynamic computational processes underlying inhibition or considered the fact that individuals with BN oscillate between two extremes-under-controlled and over-controlled intake. The proposed study combines neuroimaging with computational modeling to investigate the influences of acute fasting and eating (i.e., metabolic states) on how the brains of women with bulimia nervosa (BN) adaptively prepare for and exert inhibitory control. More specifically, the study has the following main objectives: 1) To determine whether eating and fasting affect adaptive inhibitory control and related frontostriatal activation abnormally in BN; 2) To identify associations of BN severity with state-specific frontostriatal activation and behavior.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date July 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Female - Aged 18 to 35 years - Currently between 85 and 130% of the expected weight for height - Right-handed - English-speaking Additional Inclusion Criteria for Women with Bulimia Nervosa: ° Meet DSM-5 criteria for bulimia nervosa Exclusion Criteria: - Medical instability - Ongoing medical treatment, medical condition, or psychiatric disorder that may interfere with study variables or participation - Shift work - Pregnancy, planned pregnancy, or lactation during the study period - Allergy to any of the ingredients in or unwillingness to consume the standardized meal or unwillingness to drink water during the fasting period - Any contraindication for fMRI

Study Design


Related Conditions & MeSH terms


Intervention

Other:
fasting state
16 hours of fasting
fed state
fed a standardized meal
magnetic resonance imaging
neuroimaging with computational modeling

Locations

Country Name City State
United States Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai New York New York

Sponsors (2)

Lead Sponsor Collaborator
Icahn School of Medicine at Mount Sinai National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary P(stop) at fasting state Frontostriatal activation associated with the predicted likelihood that upcoming inhibition is needed (P(stop)) at 16 hours after fast
Primary Prediction errors at fasting state Frontostriatal activation associated with: inhibitory control prediction errors (signed and unsigned) at 16 hours after fast
Primary Successful inhibition at fasting state Frontostriatal activation associated with successful inhibition at 16 hours after fast
Primary P(stop) at fed state Frontostriatal activation associated with the predicted likelihood that upcoming inhibition is needed (P(stop)) at 30 minutes after a standardized meal
Primary Prediction errors at fed state Frontostriatal activation associated with inhibitory control prediction errors (signed and unsigned) at 30 minutes after a standardized meal
Primary Successful inhibition at fed state Frontostriatal activation associated with successful inhibition at 30 minutes after a standardized meal
Secondary Stop Signal Reaction Time (SSRT) at fasting state Behavioral performance on the stop signal task, as measured by stop signal reaction time at 16 hours after fast
Secondary Stop Signal Reaction Time (SSRT) at fed state Behavioral performance on the stop signal task, as measured by stop signal reaction time at 30 minutes after a standardized meal
Secondary Stop Signal Task Performance at fasting state Percent correct responses to stop trial on Stop Signal Task Performance at 16 hours after fast
Secondary Stop Signal Task Performance at fed state Percent correct responses to stop trial on Stop Signal Task Performance at 30 minutes after a standardized meal
Secondary Frequency of Eating Disorder Symptom Episodes The frequency of binge eating episodes, self-induced vomiting episodes, and fasting episodes as assessed by the Eating Disorder Examination (EDE). Frequency of episodes assessed with no minimum or maximum limit. Baseline (At study screening)
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Withdrawn NCT02978742 - Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder N/A
Withdrawn NCT00988481 - Topiramate Augmentation in Bulimia Nervosa Partial Responders Phase 4
Completed NCT00522769 - Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents Phase 1/Phase 2
Completed NCT00184301 - A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder. N/A
Completed NCT00304187 - Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa Phase 2
Recruiting NCT05509257 - Naltrexone Neuroimaging in Teens With Eating Disorders Early Phase 1
Recruiting NCT05937243 - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating N/A
Recruiting NCT05862389 - Study on the Mechanism of Eating Disorder
Recruiting NCT05728021 - Smartphone-based Aftercare for Inpatients With Bulimia Nervosa N/A
Completed NCT03781921 - The Neural Bases of Emotion Regulation in Bulimia Nervosa
Completed NCT02553824 - FDA Approved Medication to Reduce Binge Eating and/or Purging Phase 1
Terminated NCT04041024 - Decision-making and Risk-taking in Bulimia N/A
Completed NCT04265131 - Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome? N/A
Recruiting NCT06431854 - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program N/A
Recruiting NCT02960152 - Periodontal Impact of Eating Disorders (the PERIOED Study) N/A
Completed NCT00916071 - Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders N/A
Terminated NCT00308776 - Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa N/A
Completed NCT03712748 - Online Imaginal Exposure N/A